Parent Management Training to Treat Irritability
PMT
The Efficacy of Parent Management Training to Treat Irritability
1 other identifier
interventional
36
1 country
1
Brief Summary
The goal of this clinical trial is to see if 12 sessions of a Parent Management Training program can treat irritability in children aged 10-14 years old. The main question it aims to answer are:
- Can a Parent Management Training for parents reduce anger outbursts and cranky moods in their children?
- Can Parent Management Training be done in an outpatient clinic and do parents like it? Up to 18 families can join this study. This study will be used to set up a larger study in the Fall of 2025. Parent participants will complete 12 sessions of Parent Management Training for Irritability. Each session will be 45-55 minutes weekly. They will also participate in the assessments of their child before, during and after treatment. Child participants will do assessments before, during and after the Parent Management Training treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 25, 2023
CompletedFirst Posted
Study publicly available on registry
August 31, 2023
CompletedStudy Start
First participant enrolled
June 12, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
January 7, 2026
January 1, 2026
1 year
August 25, 2023
January 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Demonstrate the feasibility of Parent Management Training (PMT) procedures
The study team will implement a PMT protocol with fidelity and acceptability assessments. A member of the study team will complete independent fidelity ratings of 50% of recorded sessions using the Cognitive Behavior Therapy for Irritability Adherence Scale. The Working Alliance Inventory (WAI) (revised short form) will be used by the clinician and the parent to rate engagement in treatment after each PMT session. There are no established benchmarks for this measure, but it will provide information about the acceptability of the treatment by rating the alliance between the therapist and the parent.
5 months
Secondary Outcomes (1)
Change in irritability
5 months
Study Arms (1)
Parent Management Training
EXPERIMENTAL12 sessions of manualized Parent Management Training for irritability developed by the National Institute of Mental Health.
Interventions
developing parenting skills and competencies dealing with oppositional and irritable behaviors in the child.
Eligibility Criteria
You may qualify if:
- clinically significant irritability (Clinician Affective Reactivity Index 30 or greater)
- parent or guardian willing to participate in treatment with the child
You may not qualify if:
- psychiatric instability (danger to self/others, risky substance abuse)
- current active Post-Traumatic Stress Disorder (PTSD) or a severe active stressor (e.g. child abuse)
- history of severe psychopathology with an established alternate treatment (e.g. autism spectrum disorder, bipolar disorder, schizophrenia, intellectual disability)
- general medical condition that may be driving irritability or prevent generalizable physiologic measures.
- screen positive for an intellectual disability via Wechsler Abbreviated Scale of Intelligence Second Edition (WASI II) estimated Intelligence Quotient (IQ)\<70.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Childrens Hospital Colorado
Aurora, Colorado, 80045, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joel Stoddard, MD
University of Colorado Denver, Anschutz Medical Campus
- PRINCIPAL INVESTIGATOR
Joel Stoddard, MD
University of Colorado Denver Anschutz
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 25, 2023
First Posted
August 31, 2023
Study Start
June 12, 2025
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
January 7, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share